MXPA04002418A - 17alfa-hidroxi-14-beta-esteroides con efecto hormonal. - Google Patents
17alfa-hidroxi-14-beta-esteroides con efecto hormonal.Info
- Publication number
- MXPA04002418A MXPA04002418A MXPA04002418A MXPA04002418A MXPA04002418A MX PA04002418 A MXPA04002418 A MX PA04002418A MX PA04002418 A MXPA04002418 A MX PA04002418A MX PA04002418 A MXPA04002418 A MX PA04002418A MX PA04002418 A MXPA04002418 A MX PA04002418A
- Authority
- MX
- Mexico
- Prior art keywords
- 14beta
- 17alpha
- steroids
- hydroxy
- hormonal effect
- Prior art date
Links
- 230000003054 hormonal effect Effects 0.000 title 1
- 231100000508 hormonal effect Toxicity 0.000 title 1
- 229910052739 hydrogen Inorganic materials 0.000 abstract 3
- 125000004178 (C1-C4) alkyl group Chemical group 0.000 abstract 2
- 239000003098 androgen Substances 0.000 abstract 2
- 239000001257 hydrogen Substances 0.000 abstract 2
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 abstract 1
- 125000002252 acyl group Chemical group 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 150000002431 hydrogen Chemical group 0.000 abstract 1
- 230000003637 steroidlike Effects 0.000 abstract 1
- 238000011282 treatment Methods 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
- C07J1/0051—Estrane derivatives
- C07J1/0062—Estrane derivatives substituted in position 17 alfa not substituted in position 17 beta
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/16—Masculine contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
- A61P5/26—Androgens
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Endocrinology (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Reproductive Health (AREA)
- Diabetes (AREA)
- Steroid Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP01203455 | 2001-09-12 | ||
| PCT/EP2002/010041 WO2003022864A1 (en) | 2001-09-12 | 2002-09-06 | 17alpha-hydroxy-14beta-steroids with hormonal effect |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MXPA04002418A true MXPA04002418A (es) | 2004-07-30 |
Family
ID=8180920
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MXPA04002418A MXPA04002418A (es) | 2001-09-12 | 2002-09-06 | 17alfa-hidroxi-14-beta-esteroides con efecto hormonal. |
Country Status (28)
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TWI221154B (en) | 2001-09-12 | 2004-09-21 | Akzo Nobel Nv | 17alpha-hydroxy-14beta-steroids with hormonal effect |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3338925A (en) * | 1965-10-25 | 1967-08-29 | Syntex Corp | 17-substituted 14beta-estr-4-enes |
| CA2359218A1 (en) | 1999-03-08 | 2000-09-14 | Akzo Nobel N.V. | 14.beta., 17-alpha-hydroxymethylandrostane derivatives as androgens |
| AU4299301A (en) * | 2000-02-29 | 2001-09-12 | National University Of Singapore, The | A method for modulating steroidogenic activity |
| US6391868B2 (en) * | 2000-05-10 | 2002-05-21 | Lpt Research, Inc. | Use of 5-alpha-androst-1-en-3,17-dione to increase the level of the anabolic/androgenic hormone 17-beta-hydroxy-5-alpha-androst-1-en-3-one in humans |
| TWI221154B (en) | 2001-09-12 | 2004-09-21 | Akzo Nobel Nv | 17alpha-hydroxy-14beta-steroids with hormonal effect |
-
2002
- 2002-07-19 TW TW091116164A patent/TWI221154B/zh not_active IP Right Cessation
- 2002-09-06 EP EP02777036A patent/EP1427748B1/en not_active Expired - Lifetime
- 2002-09-06 HU HU0402139A patent/HUP0402139A3/hu unknown
- 2002-09-06 WO PCT/EP2002/010041 patent/WO2003022864A1/en not_active Ceased
- 2002-09-06 NZ NZ531487A patent/NZ531487A/en not_active IP Right Cessation
- 2002-09-06 RU RU2004110934/04A patent/RU2294332C2/ru not_active IP Right Cessation
- 2002-09-06 DK DK02777036T patent/DK1427748T3/da active
- 2002-09-06 US US10/489,456 patent/US7169769B2/en not_active Expired - Lifetime
- 2002-09-06 AT AT02777036T patent/ATE395352T1/de active
- 2002-09-06 AU AU2002339536A patent/AU2002339536B2/en not_active Expired
- 2002-09-06 ES ES02777036T patent/ES2305306T3/es not_active Expired - Lifetime
- 2002-09-06 MX MXPA04002418A patent/MXPA04002418A/es active IP Right Grant
- 2002-09-06 DE DE60226623T patent/DE60226623D1/de not_active Expired - Lifetime
- 2002-09-06 PL PL368727A patent/PL207493B1/pl not_active IP Right Cessation
- 2002-09-06 JP JP2003526937A patent/JP4471653B2/ja not_active Expired - Fee Related
- 2002-09-06 HR HR20040193A patent/HRP20040193A2/hr not_active Application Discontinuation
- 2002-09-06 IL IL16045102A patent/IL160451A0/xx unknown
- 2002-09-06 CA CA2505575A patent/CA2505575C/en not_active Expired - Lifetime
- 2002-09-06 BR BR0212409-2A patent/BR0212409A/pt not_active IP Right Cessation
- 2002-09-06 CN CNB02817853XA patent/CN1257913C/zh not_active Expired - Lifetime
- 2002-09-06 KR KR1020047003609A patent/KR100940054B1/ko not_active Expired - Fee Related
- 2002-09-06 PT PT02777036T patent/PT1427748E/pt unknown
- 2002-09-10 AR ARP020103415A patent/AR036462A1/es unknown
-
2004
- 2004-02-18 IL IL160451A patent/IL160451A/en not_active IP Right Cessation
- 2004-02-26 IS IS7165A patent/IS2555B/is unknown
- 2004-03-10 NO NO20041010A patent/NO326624B1/no not_active IP Right Cessation
- 2004-03-10 EC EC2004005012A patent/ECSP045012A/es unknown
- 2004-03-11 ZA ZA200401992A patent/ZA200401992B/en unknown
-
2008
- 2008-06-19 CY CY20081100653T patent/CY1108152T1/el unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BR0104654A (pt) | Artigo absorvente | |
| ES2193874A1 (es) | Compuestos naturales y derivados de estos para la prevencion y el tratamiento de enfermedades cardiovasculares, hepaticas, renales y cosmeticas. | |
| WO2002094275A8 (en) | Use of estrogen compounds to increase libido in women | |
| IS7037A (is) | Notkun HMG hluta sem bólgueyðandi efni | |
| NO20032805L (no) | Blandinger med ostrogen-syklodekstrinkomplekser | |
| SG125957A1 (en) | Composition for removing residues from the microstructure of an object | |
| NZ331326A (en) | Non-steroidal polycyclic ring sulphamate derivatives, comprising two or more rings wherein at least two of the rings mimic the A and B rings of oestrone, the preparation and their use as oestrone sulphatase inhibitors | |
| ES2189768T3 (es) | Sintesis regioselectiva de derivados de rapamicina. | |
| NZ524559A (en) | 2-amino-2-alkyl-4 hexenoic and hexynoic acid derivatives useful as nitric oxide synthase inhibitors | |
| EP1340755A4 (en) | AGENT WITH EFFECT AGAINST HELICOBACTER | |
| PE20010330A1 (es) | Androgenos oralmente activos | |
| EP1191923A4 (en) | ANTIOXIDANT COMPOSITIONS FOR PROPHYLACTIC, THERAPEUTIC AND INDUSTRIAL USE IMPROVED BY STABILIZED ATOMIC HYDROGEN, AND / OR FREE ELECTRONS AND METHODS OF PREPARING AND USING SAME | |
| MX2010005350A (es) | Composicion para el cuidado personal. | |
| GB0121580D0 (en) | Novel compounds | |
| PL352638A1 (en) | Novel derivatives and analogues of galanthamin | |
| NO20033959D0 (no) | Benzimidazoler som er nyttige i behandling av seksuell dysfunksjon | |
| MXPA04002418A (es) | 17alfa-hidroxi-14-beta-esteroides con efecto hormonal. | |
| MXPA03001081A (es) | Medicamento anti-inflamatorio. | |
| WO2003082894A3 (en) | C-17 spirolactonization and 6,7 oxidation of steroids | |
| HU0203193D0 (cg-RX-API-DMAC7.html) | ||
| GB0108903D0 (en) | Novel crystalline forms of a factor Xa inhibitor | |
| MXPA03000313A (es) | Uso de fosfato de estramustina en el tratamiento de metastasis osea. | |
| TH83886B (th) | 17แอลฟา-ไฮดรอกซิ-14บีตา-สเทียรอยด์ที่มีผลของฮอร์โมน | |
| PE20020752A1 (es) | Esteroides con doble enlace delta 14 sustituido en las posiciones 13 y 14 con actividad androgenica y progestagena | |
| HRP20031068A2 (en) | Chloromethylation of thiophene |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| GB | Transfer or rights | ||
| FG | Grant or registration |